切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2019, Vol. 08 ›› Issue (06) : 493 -496. doi: 10.3877/cma.j.issn.2095-3232.2019.06.007

所属专题: 文献

临床研究

术前断流术及消化道出血对肝硬化门静脉高压症患者肝移植疗效的影响
蔡秋程1, 蔡思奕1, 阮清1, 杨芳1, 江艺1,()   
  1. 1. 350025 解放军联勤保障部队第九〇〇医院肝胆外科
  • 收稿日期:2019-07-18 出版日期:2019-12-10
  • 通信作者: 江艺
  • 基金资助:
    福建省自然科学基金面上项目(2016J01585)

Effect of preoperative devascularization and impact of gastrointestinal hemorrhage on the efficacy of liver transplantation for cirrhotic portal hypertension patients

Qiucheng Cai1, Siyi Cai1, Qing Ruan1, Fang Yang1, Yi Jiang1,()   

  1. 1. Department of Hepatobiliary Surgery, the 900th Hospital of PLA Joint Logistics Support Force, Fuzhou 350025, China
  • Received:2019-07-18 Published:2019-12-10
  • Corresponding author: Yi Jiang
  • About author:
    Corresponding author: Jiang Yi, Email:
引用本文:

蔡秋程, 蔡思奕, 阮清, 杨芳, 江艺. 术前断流术及消化道出血对肝硬化门静脉高压症患者肝移植疗效的影响[J]. 中华肝脏外科手术学电子杂志, 2019, 08(06): 493-496.

Qiucheng Cai, Siyi Cai, Qing Ruan, Fang Yang, Yi Jiang. Effect of preoperative devascularization and impact of gastrointestinal hemorrhage on the efficacy of liver transplantation for cirrhotic portal hypertension patients[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2019, 08(06): 493-496.

目的

探讨术前断流术和消化道出血对肝硬化门静脉高压症患者肝移植疗效的影响。

方法

回顾性分析2005年1月至2015年12月在解放军联勤保障部队第九○○医院行肝移植的110例肝硬化门静脉高压症患者临床资料。患者均签署知情同意书,符合医学伦理学规定。其中男84例,女26例;年龄7~75岁,中位年龄46岁。根据术前有无断流术史和消化道出血史,将患者分为断流组(19例),非断流组(91例)及出血组(66例),非出血组(44例)。分析术前断流术及消化道出血对患者预后的影响。两组术中出血量、输液量等比较采用t检验,率的比较采用χ2检验。

结果

断流组患者术后并发症发生率和5年累积生存率分别为42%、74%,明显高于非断流组的19%、88%(χ2=4.91,2.56;P<0.05)。断流组术中出血量、输液量、手术时间、住院费用分别为(4 135±2 696)ml、(11 068±3 461)ml、(511±126)min、(28±9)万元,明显高于非断流组的(3 202±1 122)ml、(7 275±2 346)ml、(396±85)min、(24±5)万元(t=2.46,6.36,4.90,2.71;P<0.05)。出血组和非出血组上述指标比较,差异均无统计学意义(P>0.05)。

结论

术前断流术增加肝硬化门静脉高压症患者肝移植的难度,术后风险高,而消化道出血对肝移植疗效无明显影响。

Objective

To evaluate the effect of preoperative devascularization and the impact of gastrointestinal hemorrhage on the efficacy of liver transplantation for cirrhotic portal hypertension patients.

Methods

Clinical data of 110 patients with cirrhotic portal hypertension undergoing liver transplantation in the 900th Hospital of PLA Joint Logistics Support Force from January 2005 to December 2015 were retrospectively analyzed. The informed consents of all patients were obtained and the local ethical committee approval was received. Among them, 84 patients were male and 26 female, aged 7-75 years with a median of 46 years. According to the history of preoperative devascularization and gastrointestinal hemorrhage, the patients were divided into the devascularization (n=19) and non-devascularization (n=91) groups, hemorrhage (n=66) and non-hemorrhage groups (n=44). The effect of preoperative devascularization and gastrointestinal hemorrhage on prognosis of patients was evaluated. Intraoperative blood loss and infusion volume between two groups were compared by t test. The rate comparison was performed by Chi-square test.

Results

The incidence of postoperative complications and the 5-year cumulative survival rate in devascularization group were 42% and 74%, significantly higher than 19% and 88% in non-devascularization group (χ2=4.91, 2.56; P<0.05). In devascularization group, intraoperative blood loss, infusion volume, operation time and hospitalization expense were (4 135±2 696) ml, (11 068±3 461) ml, (511±126) min, (280±90)×103 Yuan, respectively, significantly higher than (3 202±1 122) ml, (7 275±2 346) ml, (396±85) min, (240±50)×103 Yuan in non-devascularization group (t=2.46, 6.36, 4.90, 2.71; P<0.05). No significant difference was observed between the hemorrhage and non-hemorrhage groups (all P>0.05).

Conclusions

Preoperative devascularization increases the difficulty of liver transplantation for cirrhotic portal hypertension patients and yields high postoperative risk. Nevertheless, gastrointestinal hemorrhage exerts no significant impact upon the efficacy of liver transplantation.

表1 断流组和非断流组肝硬化门静脉高压症患者肝移植术中和术后情况比较
表2 出血组和非出血组肝硬化门静脉高压症患者肝移植术中和术后情况比较
[1]
刘斌,方正亚,孟冬梅.肝硬化并发症及预防研究进展[J].中华实用诊断与治疗杂志,2016, 30(12):1152-1155.
[2]
严律南.肝硬变门脉高压的肝脏移植经验[J].中国普外基础与临床杂志,2001, 8(4):263-264.
[3]
中华医学会传染病与寄生虫学分会、肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志,2000, 8(6):324-329.
[4]
中华消化内镜学会.食管胃底静脉曲张内镜下诊断和治疗规范试行方案[J].中华消化内镜杂志,2000, 17(4):198-199.
[5]
中华医学会外科学分会门静脉高压学组.肝硬化门静脉高压食管、胃底静脉曲张破裂出血的诊治共识(2015版)[J].中华外科杂志,2015, 53(12):917-921.
[6]
程远,蔡秋程,江艺.下腔静脉逆行再灌注法在原位肝移植中的应用进展[J].器官移植,2016, 7(6):479-483.
[7]
Orozco H, Mercado MA, Chan C, et al. A comparative study of the elective treatment of variceal hemorrhage with beta-blockers transendoscopicselerotherapy and surgery. a prospective, controlled, and randomized trial during 10 years[J]. Ann Surg, 2000, 232(2):216-219.
[8]
宋维平,杨长青.2016年美国肝病学会肝硬化门静脉高压出血的风险分层、诊断和管理实践指导[J].上海大学学报,2018, 24(3): 336-340.
[9]
Vorobioff JD, Groszmann RJ. Prevention of portal hypertension: from variceal development to clinical to decompensation[J]. Hepatology, 2015, 61(1):375-381.
[10]
Gareia-Tsao G, Bosch J. Management of varices and variceal hemorrhage in cirrhosis[J]. N Engl J Med, 2010, 362(9):823-832.
[11]
Loren L. Primary prophylaxis of esophageal variceal bleeding: anendoscopic approach[J]. Hepatology, 2010, 52(6):944-945.
[12]
Vignali C, Bargellini I, Grosso M, et al. TIPS with expanded polyterafluoroethylene-covered stent: results of an Italian multi-center study[J]. Am J Roentgenol, 2005, 185(2):472-480.
[13]
Gur I, Diggs BS, Orloff SL. Surgical portosystemic shunts in the era of TIPS and liver transplantation are still relevant[J]. HPB, 2014, 16(5):481-493.
[14]
潘洪旭.肝硬化门静脉高压症合并上消化道出血患者的临床治疗研究[J].中国医药指南,2015, 13(1):116-117.
[15]
Unger LW, Berlakovich G, Trauner M, et al. Management of portal hypertension before and after liver transplantation[J]. Liver Transpl, 2018, 24(1):112-121.
[16]
霍枫,陈建雄,郑于剑,等.肝移植治疗门静脉高压症的作用与地位及需要注意的问题[J].中华消化外科杂志,2018, 17(10):976-980.
[17]
李铁汉,唐波,田大广,等.脾切除术后门静脉系统血栓形成的临床分析[J].腹部外科,2010, 23(6):341-343.
[18]
Jonathan GS, Puja MS, Scott LC, et al. Portal vein thrombosis, morality and hepatic decompensation in patients with cirrhosis:a meta-analysis[J]. World J Hepatol, 2015, 7(27):2774-2780.
[19]
蔡秋程,吕立志,陈少华,等.肝移植术中供肝门静脉与受体结肠中动脉吻合并脾切除一例[J].中华器官移植杂志,2009, 30(6): 382.
[20]
Lai JC, Dodge JL, Sen S, et al. Functional decline in patients with cirrhosis awaiting liver transplantation: results from the functional assessment in liver transplantation (FrAILT) study[J]. Hepatology, 2016, 63(2): 574-580.
[1] 王宏宇. 固定与活动平台假体在全膝关节置换术中的应用价值[J]. 中华关节外科杂志(电子版), 2023, 17(06): 871-876.
[2] 许正文, 李振, 侯振扬, 苏长征, 朱彪. 富血小板血浆联合植骨治疗早期非创伤性股骨头坏死[J]. 中华关节外科杂志(电子版), 2023, 17(06): 773-779.
[3] 高玲, 于哲, 范然, 臧银善. 外周血细胞计数比值评估类风湿关节炎疗效的价值[J]. 中华关节外科杂志(电子版), 2023, 17(05): 642-647.
[4] 王泽勇, 覃健. 白细胞含量对富血小板血浆治疗运动系统损伤的影响[J]. 中华关节外科杂志(电子版), 2023, 17(05): 684-688.
[5] 李坤河, 寇萌佳, 邝立挺. 肝移植术后二次气管插管的危险因素及预测模型的建立[J]. 中华普通外科学文献(电子版), 2023, 17(05): 366-371.
[6] 李建美, 邓静娟, 杨倩. 两种术式联合治疗肝癌合并肝硬化门静脉高压的安全性及随访评价[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 41-44.
[7] 陈垚, 徐伯群, 高志慧. 改良式中间上入路根治术治疗甲状腺癌的有效性安全性研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 619-622.
[8] 张海涛, 康婵娟, 翟静洁. 胰管支架置入治疗急性胆源性胰腺炎效果观察[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 654-657.
[9] 张其坤, 商福超, 李琪, 栗光明, 王孟龙. 联合脾切除对肝癌合并门静脉高压症患者根治性切除术后的生存获益分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 613-618.
[10] 严庆, 刘颖, 邓斐文, 陈焕伟. 微血管侵犯对肝癌肝移植患者生存预后的影响[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 624-629.
[11] 廖梅, 张红君, 金洁玚, 吕艳, 任杰. 床旁超声造影对肝移植术后早期肝动脉血栓的诊断价值[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 630-634.
[12] 李秉林, 吕少诚, 潘飞, 姜涛, 樊华, 寇建涛, 贺强, 郎韧. 供肝灌注液病原菌与肝移植术后早期感染的相关性分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 656-660.
[13] 吕垒, 冯啸, 何凯明, 曾凯宁, 杨卿, 吕海金, 易慧敏, 易述红, 杨扬, 傅斌生. 改良金氏评分在儿童肝豆状核变性急性肝衰竭肝移植手术时机评估中价值并文献复习[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 661-668.
[14] 王孟龙. 肿瘤生物学特征在肝癌肝移植治疗中的意义[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 490-494.
[15] 王峰杰, 王礼光, 廖珊, 刘颖, 符荣党, 陈焕伟. 腹腔镜右半肝切除术治疗肝癌的安全性与疗效[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 517-522.
阅读次数
全文


摘要